Lampgen Advisory · Clinical operations consulting

Find what’s putting your oncology study milestone at risk.

When a decision keeps moving between the sponsor, CRO, and study team, Lampgen Advisory helps identify where execution is breaking down, who should own the next decision, and how to check that the action worked.

FIRST PAID ENGAGEMENT

CRO Oversight Diagnostic

Scope the diagnostic to one study and one decision. We examine the milestone, relevant issue records, decision authority, and handoffs. You receive a short evidence summary, a recommended action, a proposed decision owner, and one measure of follow-through.

We agree on scope and fee after the briefing. If you need help implementing the recommendation, we scope that work separately and agree on how to review progress with your team.

Bring a decision your team needs to make.

Decision ownership

Escalations move between the sponsor and CRO without a named approver or decision date.

Milestone readiness

Site activation, cohort expansion, or database lock depends on handoffs across teams.

Recurring issues

Corrective actions are recorded, and your team needs a clearer way to check whether the issue recurs.

FOR ONCOLOGY SPONSORS

Request an executive briefing.

Tommy Lampley Jr., Founder of Lampgen Clinical Research, leads the briefing. Bring one upcoming milestone and the decision your team is working through.

For ongoing review with an existing team, explore SIGNAL Managed Monitoring. For a defined role, request oncology staffing.

Tell us about the decision

Use general study details. Keep participant information and confidential protocol details out of the form.

Your submission is complete only when you see the confirmation. You can also call or text (770) 609-5044.